Galectin Therapeutics
GALT
#9131
Rank
โ‚ฌ73.35 M
Marketcap
1,16ย โ‚ฌ
Share price
-7.04%
Change (1 day)
-64.41%
Change (1 year)

Earnings for Galectin Therapeutics (GALT)

Earnings in 2024 (TTM): -โ‚ฌ43.73 Million

According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚ฌ36.13 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Galectin Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ41.39 Million14.56%
2023 -โ‚ฌ36.13 Million5.91%
2022 -โ‚ฌ34.11 Million27.02%
2021 -โ‚ฌ26.86 Million30.1%
2020 -โ‚ฌ20.64 Million76.51%
2019 -โ‚ฌ11.7 Million-4.36%
2018 -โ‚ฌ12.23 Million-14.38%
2017 -โ‚ฌ14.29 Million-24.26%
2016 -โ‚ฌ18.86 Million7.04%
2015 -โ‚ฌ17.62 Million26.85%
2014 -โ‚ฌ13.89 Million30.61%
2013 -โ‚ฌ10.64 Million27.82%
2012 -โ‚ฌ8.32 Million-9.15%
2011 -โ‚ฌ9.16 Million113.17%
2010 -โ‚ฌ4.3 Million-19.86%
2009 -โ‚ฌ5.36 Million14.4%
2008 -โ‚ฌ4.69 Million-17.49%
2007 -โ‚ฌ5.68 Million-8.41%
2006 -โ‚ฌ6.2 Million5.91%
2005 -โ‚ฌ5.86 Million-8.89%
2004 -โ‚ฌ6.43 Million47.92%
2003 -โ‚ฌ4.35 Million50.22%
2002 -โ‚ฌ2.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.68 Billion 1,525.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ26.84 M-164.87%๐Ÿ‡บ๐Ÿ‡ธ USA